L-NAME inhibits Mg2+-induced rat aortic relaxation in the absence of endothelium

British Journal of Pharmacology

Volumn 128, Issue 2, 1999, Pages 493-499

  Das, Rapti ^a   Kravtsov, Gennadi M ^a   Ballard, Heather J ^a   Kwan, Chiu Yin ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Aorta; Calcium; Endothelium; L NAME; Magnesium; Nitric oxide; Vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; AMINOGUANIDINE; CELL MEMBRANE PROTEIN; DEXAMETHASONE; MAGNESIUM ION; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NICKEL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ISOMETRIC CONTRACTION; MAGNESIUM; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; OMEGA-N-METHYLARGININE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032861295     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702737     Document Type: Article

References (33)

1. ADEAGBO, A.S.O. & TRIGGLE, C.R. (1993). Interactions of nitric oxide synthase inhibitors and dexamethasone with α-adrenoceptor-mediated responses in rat aorta. Br. J. Pharmacol., 109, 495-501.
2. ALTURA, B.M. & ALTURA, B.T. (1974). Magnesium and contraction of arterial smooth muscle. Microvasc. Res., 7, 145-155.
3. BLACKBURN, K. & HIGHSMITH, R.F. (1990). Nickel inhibits endothelin-induced contraction of vascular smooth muscle. Am. J. Physiol., 258, C1025-C1030.
4. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res., 72, 387-395.
5. CORBETT, H.J., TILTON, R.G., CHANG, K., HASAN, K.S. & IDO, Y. (1992). Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes, 41, 552-556.
6. DURAL, D., FUNDER, J.W., DEVYNCK, M. & MEYER, P. (1977). Arterial glucocorticoid receptors: the binding of tritiated dexamethasone in rabbit aorta. Cardiovasc. Res., 11, 529-535.
7. FURCHGOTT, R.F. (1983). Role of endothelium in responses of vascular smooth muscle. Circ. Res., 53, 557-573.
8. FURCHGOTT, R.F. & ZAWADSKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
9. FURCHGOTT, R.F., ZAWADSKI, J.V. & CHERRY, P.D. (1981). Role of endothelium in the vasodilator response to acetylcholine. In Vasodilation eds. P.M. Vanhoutte, I. Leusen. pp. 49-66. New York. Raven Press.
10. GOLD, M.E., BUGA, G.M., WOOD, K.S., BYRNS, R.E., CHAUDHURI, G. & IGNARRO, L.J. (1990). Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone. Circ. Res., 66, 355-366.
11. GRIFFITHS, M.J.D., MESSENT, M., MACALLISTER, R.J. & EVANS, T.W. (1993). Aminoquanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110, 963-968.
12. GUAN, Y.Y., KWAN, C.Y. & DANIEL, E.E. (1988). Inhibition of norepinephrine-induced contractile responses of canine mesenteric artery by plan saponins. Blood Vessels, 25, 312-315.
13. HIKI, K., YUI, Y., HATTORI, R., EIZAWA, H., KOSUGA, K. & KAWAI, C. (1991). Cytosolic and membrane-bound nitric oxide synthase. Jpn. J. Pharmacol., 56, 217-220.
14. HECKER, M., WALSH, D.T. & VANE, Z. (1992). Characterization of a microsomal calcium-dependent nitric oxide synthase in activated J774.2 monocyte/macrophages. J. Cardiovasc. Pharmacol., 20, S139-S141.
15. G-nitro L-arginine and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem. Biophys. Res. Comm., 199, 147-154.
16. KANNO, K., HIRATA, Y., IMAI, T. & MARUMO, F. (1993). Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension, 22, 34-39.
17. KORNEL, L., KANARMARLAPUDI, N., TRAVERS, T., TAFF, D., PATEL, N., CHEN, C., BAUM, R. & RAYNOR, W. (1981). Studies on high affinity binding of mineralo- and gluco-corticoids in rabbit aorta cytosol. J. Steroid Biochem., 16, 282-293.
18. KRAVTSOV, G.M. & KWAN, C.Y. (1995). A revisitation on the mechanism of action of KCl-induced vascular smooth muscle contraction: a key role of cation binding to the plasma membrane. Biol. Signals., 4, 160-167.
19. MARTELL, A.E. & SMITH, R.M. (1974). Critical Stability Constants, Plenum Publishing Corp., New York.
20. 5-[imino-nitro-amino methyl]-L-Ornithine) impairs endothelium-dependent dilatations by inhibiting cytosolic NO synthesis from L-arginine. Naunyn-Schmiedebergs Arch. Pharmacol., 341, 143-147.
21. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize NO from L-arginine. Nature, 333, 664-666.
22. PALMER, R.M., ANDREWS, T., FOXWELL, N.A. & MONCADA, S. (1992). Glucocorticoids do not affect the reduction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem. Biophys. Res. Commun., 188, 209-215.
23. PETERSON, D.S., PETERSON, D.C., ARCHER, S. & WEIR, E.K. (1992). The nonspecificity of specific NO synthase inhibitors. Biochem. Biophys. Res. Commun., 187, 797-801.
24. REES, D.D., PALMER, R.M.J., HODSON, F.H. & MONCADA, S. (1989). A specific inhibitor of NO formation from L-arginine attenuates endothelial dependent relaxation. Br. J. Pharmacol., 96, 418-424.
25. REES, D.D., PALMER, R.M.J., SCHULZ, R., HODSON, F.H. & MONCADA, S. (1990). Characterisation of three inhibitors of endothelial NO synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
26. SALAPATEK, A.M.F., WANG, Y.F., MAO, Y.K., LAM, A. & DANIEL, E.E. (1998). Myogenic nitric oxide synthase activity in canine lower oesophageal sphincter: morphological and functional evidence. Br. J. Pharmacol., 123, 1055-1064.
27. SAMATA, K., KIMURA, T., SATOH, S. & WATANABE, H. (1986). Chemical removal of the endothelium by saponin in the isolated dog femoral artery. Eur. J. Pharmacol., 128, 85-91.
28. 28Mg with Ca and K in the smooth muscle of guinea-pig taenia-coli. J. Physiol. (Lond.)., 205, 19-38.
29. G-Monomethyl L-arginine. J. Pharmacol. Exp. Ther., 260, 676-679.
30. TURLAPATY, P.D.M.V. & ALTURA, B.M. (1983). Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur. J. Pharmacol., 52, 421-423.
31. VAN DE VOORDE, J. & LEUSEN, I. (1983). Role of endothelium in the vasodilator response of rat thoracic aorta to histamine. Eur. J. Pharmacol., 79, 531-541.
32. G-nitro-L-arginine methyl ester in vitro and in vivo. J. Pharmacol. Exper. Ther., 267, 1091-1099.
33. w-nitro-L-arginine methyl ester in the rat aorta. Clin. Exp. Pharmacol. Physiol., 22, 641-645.